Description
DOPAZIN-5 — A Focused Dapagliflozin Dose for Everyday Diabetes Freedom
DOPAZIN-5 contains Dapagliflozin 5 mg, a selective SGLT2 inhibitor that lowers blood glucose by reducing renal glucose reabsorption in an insulin-independent manner. At this lower starting dose, DOPAZIN-5 is often the physician’s choice for initiating therapy or for patients who need gentler glycemic control alongside lifestyle management, making it a versatile addition for practices treating a wide range of Type 2 Diabetes patients. Beyond glucose control, dapagliflozin is also valued for its cardiovascular and renal benefits, which is why this molecule continues to see steady prescription growth, giving franchise partners a dependable entry point into the diabetology segment.
Reliability That Supports Long-Term Therapy
Lxir Medilabs is an ISO and WHO-GMP certified pharmaceutical company headquartered in Panchkula, Haryana with manufacturing carried out at our Baddi, Himachal Pradesh facility. Diabetes is a long-term condition and patients depend on consistent tablet performance over months and years of therapy, which is why DOPAZIN-5 is manufactured under strict quality control to maintain uniform potency across every batch. For a PCD pharma franchise company in India, this kind of manufacturing discipline helps field partners build lasting trust with physicians managing chronic diabetes care.
Product Highlights for Franchise Partners
- Composition: Dapagliflozin 5 mg
- Dosage Form: Tablets
- Pack Size: 10 x 14
- Pack Type: ALU ALU for enhanced stability and shelf protection
- Key Benefit: Turning diabetes management into freedom of living
- Suited For: Distributors and medical representatives expanding their diabetology range
Franchise partners looking to add a lower-dose dapagliflozin option to their diabetes portfolio can explore this and other formulations through our PCD pharma franchise division, with complete promotional support.
Disclaimer: This is a prescription product and should be used strictly under the guidance of a registered medical practitioner.
